Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125640502 | 12564050 | 2 | F | 201605 | 20160901 | 20160718 | 20160928 | PER | US-TEVA-672964USA | TEVA | 36.60 | YR | F | Y | 0.00000 | 20160928 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125640502 | 12564050 | 1 | PS | COPAXONE | GLATIRAMER ACETATE | 1 | Subcutaneous | 20622 | 40 | MG | INJECTION | TIW | |||||||
| 125640502 | 12564050 | 2 | C | TRAMADOL HCL | TRAMADOL HYDROCHLORIDE | 1 | 0 | 50 | MG | TABLET | |||||||||
| 125640502 | 12564050 | 3 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | 300 | MG | CAPSULE | |||||||||
| 125640502 | 12564050 | 4 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | 100 | MG | CAPSULE | |||||||||
| 125640502 | 12564050 | 5 | C | BACLOFEN. | BACLOFEN | 1 | 0 | 10 | MG | TABLET | |||||||||
| 125640502 | 12564050 | 6 | C | BACLOFEN. | BACLOFEN | 1 | 0 | 10 | MG | TABLET | |||||||||
| 125640502 | 12564050 | 7 | C | NAPROXEN. | NAPROXEN | 1 | 0 | 500 | MG | TABLET | |||||||||
| 125640502 | 12564050 | 8 | C | FLUTICASONE SPR | 2 | 0 | 50 | UG | |||||||||||
| 125640502 | 12564050 | 9 | C | OXYBUTYNIN | OXYBUTYNIN | 1 | 0 | 5 | MG | TABLET | |||||||||
| 125640502 | 12564050 | 10 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | 20 | MG | CAPSULE | |||||||||
| 125640502 | 12564050 | 11 | C | LORATADINE. | LORATADINE | 1 | 0 | 10 | MG | TABLET | |||||||||
| 125640502 | 12564050 | 12 | C | PEPCID | FAMOTIDINE | 1 | 0 | TABLET | |||||||||||
| 125640502 | 12564050 | 13 | C | PEPCID | FAMOTIDINE | 1 | 0 | TABLET | |||||||||||
| 125640502 | 12564050 | 14 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 0 | TABLET |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125640502 | 12564050 | Ataxia | |
| 125640502 | 12564050 | Cartilage injury | |
| 125640502 | 12564050 | Fall | |
| 125640502 | 12564050 | Injection site reaction | |
| 125640502 | 12564050 | Joint injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125640502 | 12564050 | 1 | 201505 | 0 | ||
| 125640502 | 12564050 | 2 | 20160615 | 20160814 | 0 | |
| 125640502 | 12564050 | 3 | 20160114 | 20160708 | 0 | |
| 125640502 | 12564050 | 4 | 20111004 | 0 | ||
| 125640502 | 12564050 | 5 | 20160114 | 20160708 | 0 | |
| 125640502 | 12564050 | 6 | 20111004 | 0 | ||
| 125640502 | 12564050 | 7 | 20160504 | 20160703 | 0 | |
| 125640502 | 12564050 | 8 | 20160325 | 20160629 | 0 | |
| 125640502 | 12564050 | 9 | 20160427 | 20160626 | 0 | |
| 125640502 | 12564050 | 10 | 20160427 | 20160626 | 0 | |
| 125640502 | 12564050 | 11 | 20160325 | 20160524 | 0 | |
| 125640502 | 12564050 | 12 | 20111004 | 0 | ||
| 125640502 | 12564050 | 13 | 19000101 | 0 | ||
| 125640502 | 12564050 | 14 | 20111004 | 0 |